NCT07169851 2026-04-22
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Eli Lilly and Company
Phase 2 Recruiting
Clinical Trials
6 trialsNCT07537660 2026-04-17
ADGP
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07537673 2026-04-17
ADTD
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07537699 2026-04-17
ADDC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT04449315 2026-04-15
Outpatient Oncology Aromatherapy for Symptom Management
Central DuPage Hospital
Phase NA Completed
NCT06904235 2026-03-31
Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Helsinn Healthcare SA
Phase 2 Recruiting